EARTH LIFE SCIENCES INC
CLTS$430,723
Micro CapNASDAQServices-Detective, Guard & Armored Car Services🇺🇸North AmericaMONTREAL
Drugs in Pipeline
4
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
Aug 27, 2026
24wMarket Overview
Stock performance and key metrics
CLTS News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
rhPSMA-7.3 (18F) Injection
Prostate Cancer
18F fluciclovine
Brain Metastases
18F-Fluciclovine PET CT
Cancer of the Prostate
Lutetium (177Lu) rhPSMA-10.1 Injection
Prostate Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
rhPSMA-7.3 (18F) Injection | Phase 3 | Prostate Cancer | - | - |
18F fluciclovine | Phase 3 | Brain Metastases | - | - |
18F-Fluciclovine PET CT | Phase 3 | Cancer of the Prostate | - | - |
Lutetium (177Lu) rhPSMA-10.1 Injection | Phase 2 | Prostate Cancer | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply